Sea Crest Wealth Management, LLC Chembio Diagnostics, Inc. Transaction History

Sea Crest Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$5.32 - $7.18 $2,660 - $3,590	-500 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$4.95 - $10.5 $4,950 - $10,500	-1,000 Reduced 66.67%	500 $3,000
Q3 2018 Nov 14, 2018	SELL	$9.2 - $11.5 $4,600 - $5,750	-500 Reduced 25.0%	1,500 $16,000
Q2 2018 Aug 03, 2018	SELL	$7.8 - $11.1 $39,000 - $55,500	-5,000 Reduced 71.43%	2,000 $22,000
Q4 2017 Feb 02, 2018	BUY	$5.95 - $8.35 $41,650 - $58,450	7,000	7,000 $57,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.